Share this video  

ITOC 2022 | Potentiating immunotherapy for bladder cancer via porphyrin-based PLZ4-nanoparticles

Chong Xian Pan, MD, PhD, Harvard Medical School, Boston, MA, shares insight into potentiating immunotherapy for bladder cancer via the use of phototherapy with bladder cancer-specific porphyrin-based PLZ4-nanoparticles. This interview took place at the Immunotherapy of Cancer (ITOC) Conference 2022 in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.